Xiang Gao
- Biomaterials top 1%
- Nanoparticle-Based Drug Delivery 24
- Molecular Medicine top 2%
- Pharmaceutical Science top 2%
- Immunology top 10%
- Immunotherapy and Immune Responses 14
- Immune cells in cancer 6
- Oncology top 10%
-
- RNA Interference and Gene Delivery 21
- Advanced biosensing and bioanalysis techniques 10
- Ubiquitin and proteasome pathways 5
-
- Nanoplatforms for cancer theranostics 14
-
- Glioma Diagnosis and Treatment 5
- Journals
- International Journal of Nanomedicine (7 papers)Acta Pharmaceutica Sinica B (4 papers)Nanoscale (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiang Gao
87 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Biomaterials 758
- Molecular Medicine 263
- Pharmaceutical Science 166
- Immunology 375
- Oncology 453
Countries citing papers authored by Xiang Gao
This map shows the geographic impact of Xiang Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Gao more than expected).
Fields of papers citing papers by Xiang Gao
This network shows the impact of papers produced by Xiang Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Gao. The network helps show where Xiang Gao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiang Gao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 16 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 18 | |
| 6 | Current advance of nanotechnology in diagnosis and treatment for malignant tumorsbreakdown → | 2024 | 238 |
| 7 | 2023 | 18 | |
| 8 | 2023 | 16 | |
| 9 | 2023 | 37 | |
| 10 | 2022 | 69 | |
| 11 | 2021 | 35 | |
| 12 | 2021 | 36 | |
| 13 | 2020 | 27 | |
| 14 | 2017 | 3 | |
| 15 | 2016 | 74 | |
| 16 | 2015 | 51 | |
| 17 | 2013 | 70 | |
| 18 | 2013 | 51 | |
| 19 | 2013 | 40 | |
| 20 | 2012 | 7 |
About Xiang Gao
Xiang Gao is a scholar working on Biomaterials, Molecular Medicine and Immunology, having authored 95 papers that have together received 2.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (24 papers), RNA Interference and Gene Delivery (21 papers), Nanoplatforms for cancer theranostics (14 papers), Immunotherapy and Immune Responses (14 papers), Advanced biosensing and bioanalysis techniques (10 papers), Immune cells in cancer (6 papers), Glioma Diagnosis and Treatment (5 papers) and Ubiquitin and proteasome pathways (5 papers). The work is most often cited by research in Biomaterials (758 citations), Molecular Medicine (263 citations) and Pharmaceutical Science (166 citations). Xiang Gao has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yuquan Wei, Zhiyong Qian, Yang Tian, Changqin Ding, Anwei Zhu, Bilan Wang, Gang Guo, Ting Yu, Bilan Wang and Yuzhu Hu. Their work appears in journals such as International Journal of Nanomedicine, Acta Pharmaceutica Sinica B, Nanoscale, Chinese Chemical Letters and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.